Erin Stacy-Hamilton
Family · Batavia, OHNPI 1508528373
Payments from drug & device makers
Across 72 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$484
- AstraZeneca$187
- Novo Nordisk$61
- Gilead$57
- Revance Therapeutics, Inc.$52
- Lilly USA, LLC$49
- plus $378 from 14 others
What the payments were for
- Food & beverage$1,268100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $484 |
| AstraZeneca | 12 | $187 |
| Novo Nordisk | 4 | $61 |
| Gilead | 3 | $57 |
| Revance Therapeutics, Inc. | 1 | $52 |
| Lilly USA, LLC | 3 | $49 |
| Medtronic | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Exact Sciences | 2 | $41 |
| Pfizer | 2 | $34 |
| Dexcom, Inc. | 2 | $34 |
| Cepheid | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Organon | 1 | $16 |
| Electromed, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
How this compares
$1,268 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 23 | $22,094 |
| MounjaroTirzepatide | 18 | $18,760 |
| OzempicSemaglutide | 13 | $14,256 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $10,000 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $5,809 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,224 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $1,039 |
| Atorvastatin Calcium | 94 | $639 |
| Levothyroxine Sodium | 80 | $498 |
| Omeprazole | 68 | $427 |
| Rosuvastatin Calcium | 44 | $412 |
| Gabapentin | 44 | $369 |
| Bupropion Hcl SrBupropion Hcl | 16 | $351 |
| Ropinirole Hcl | 14 | $328 |
| Esomeprazole Magnesium | 11 | $291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $187 | $27,90343 claims |
| Lilly USA, LLCMounjaro | $49 | $18,76018 claims |
| Novo NordiskOzempic | $61 | $14,25613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.
Other family in Batavia
- Rachel HintonBatavia$99K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.